2026 Cancer Updates Breast & Lung, Kansas City
Learn How to Claim Your Credit
The Cancer Updates Breast & Lung Conference consists of educational activities designed to meet the needs of medical oncologists, pharmacists, advanced practitioners, and nurses involved in the treatment of gastrointestinal and breast cancers. The agenda is comprised of presentations that break down the most clinically relevant information applicable to community care. This dinner program is hosted as an in-person event only.
Event Page
Accreditation Information | 1.75
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours.
-
Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours. JA4008163-9999-25-197-L01-P | JA4008163-9999-25-197-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior
-
Total Health Conferences
2026 Cancer Updates Breast and Lung, Kansas City
May 14, 2026 Kansas City, MO
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health Conferences. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation Provider Number: 4008163
Professions in scope for this activity are listed below
Physicians
Amedco LLC designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 1.75 knowledge-based CPE contact hours.
JA4008163-9999-26-133-L01-P | UAN JA4008163-9999-26-133-L01-T
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurses
Amedco LLC designates this activity for a maximum of 1.75 ANCC contact hours
Objectives - After Attending This Program You Should Be Able To
1. Review recent clinical advances in the treatment of lung and breast cancers, with a focus on the most relevant data from recent studies and clinical trials.
2. Evaluate the role of emerging therapies in breast and lung cancer treatment, including new medications, targeted therapies, and immunotherapies.
3. Apply evidence-based strategies to improve patient outcomes in community oncology settings, focusing on the integration of new treatment approaches.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5) All individuals in a position to control the content of CE are listed below.
Name Commercial Interest:Relationship
Elizabeth Butler NA J
Russell Davis NA
Whitney Hensing NA
Kelly Kapp NA
Mouhammed Kyasa NA
Yvonne Pham NA
Timothy Pluard Pfizer,BMS,Lilly,AstraZeneca, Cellcuity, BioNTech, Daiichi, Merck, , BridgeBio, Iambic, Jazz, Sermonix, Puma, Novartis:Research Grant Site Principal Investigator BiCycle, Lilly, Natera:Consultant Gilead, Stemline:Speakers Bureau
Reyna Wilhelm NA
Dana Mortenson NA
How to Get Your Certificate
1. Go to thc.cmecertificateonline.com
2. Click on the 2026 Cancer Updates Breast and Lung, Kansas City link. http://workshop-evaluator.herokuapp.com/evaluation/20469
a. This evaluation will remain online from May 14, 2026 through August 14, 2026
3. Evaluate the meeting.
4. Print, download, or save your certificate for your records.
5. If you lose your certificate, or need help, go to help.cmecertificateonline.com
How to Get Your Certificate
Go to thc.cmecertificateonline.com
Evaluate the meeting.
Print, download, or save your certificate for your records.
If you lose your certificate, or need help, go to help.cmecertificateonline.com